{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:13:03Z","timestamp":1777525983807,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","award":["99999.001482\/2015-07"],"award-info":[{"award-number":["99999.001482\/2015-07"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SSPC"},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["12\/RC\/2275"],"award-info":[{"award-number":["12\/RC\/2275"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejpb.2019.09.004","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T11:55:45Z","timestamp":1567598145000},"page":"57-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Impact of polyethylene glycol polymers on the physicochemical properties and mucoadhesivity of itraconazole nanoparticles"],"prefix":"10.1016","volume":"144","author":[{"given":"Ricardo","family":"Machado Cruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jose","family":"Santos-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Tajber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2019.09.004_b0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcp.2016.11.019","article-title":"Antifungals","volume":"133","author":"Campoy","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2019.09.004_b0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tim.2010.02.004","article-title":"Therapy for fungal diseases: opportunities and priorities","volume":"18","author":"Denning","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejpb.2019.09.004_b0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2008.05.021","article-title":"Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): theoretical basis and practical examples","volume":"361","author":"Papadopoulou","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.09.004_b0020","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.32.9.1310","article-title":"Pharmacokinetics of itraconazole following oral administration to normal volunteers","volume":"32","author":"Hardin","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2019.09.004_b0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jps.24694","article-title":"Pharmaceutical and pharmacokinetic aspect of nanocrystalline suspensions","volume":"105","author":"Shah","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.09.004_b0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2014.03.030","article-title":"Engineered nanocrystal technology: In-vivo fate, targeting and applications in drug delivery","volume":"183","author":"Pawar","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.09.004_b0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1773-2247(13)50057-8","article-title":"Amorphous drugs and dosage forms","volume":"23","author":"Grohganz","year":"2013","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2019.09.004_b0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijpharm.2014.05.045","article-title":"Heat induced evaporative antisolvent nanoprecipitation (HIEAN) of itraconazole","volume":"471","author":"Mugheirbi","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.09.004_b0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2013.05.040","article-title":"Mucus as a barrier to lipophilic drugs","volume":"453","author":"Sigurdsson","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.09.004_b0050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2015.11.003","article-title":"Mucoadhesive vs. mucopenetrating particulate drug delivery","volume":"98","author":"Netsomboon","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.09.004_b0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cocis.2010.05.015","article-title":"Mucin layers and multilayers \u2014 physicochemical properties and applications","volume":"15","author":"Svensson","year":"2010","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2019.09.004_b0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrgastro.2013.35","article-title":"The gastrointestinal mucus system in health and disease","volume":"10","author":"Johansson","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejpb.2019.09.004_b0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.09.004_b0070","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tcb.2011.06.002","article-title":"Biological hydrogels as selective diffusion barriers","volume":"21","author":"Lieleg","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejpb.2019.09.004_b0075","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/17425247.2011.586334","article-title":"Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale","volume":"8","author":"das Neves","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2019.09.004_b0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.addr.2017.10.009","article-title":"The role of mucus on drug transport and its potential to affect therapeutic outcomes","volume":"124","author":"Murgia","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.09.004_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2013.04.002","article-title":"Comparative study of Pluronic\u00ae F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats","volume":"449","author":"Chen","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.09.004_b0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2014.10.026","article-title":"Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse","volume":"197","author":"Maisel","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.09.004_b0095","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","article-title":"Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review","volume":"39","author":"Sosnik","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.ejpb.2019.09.004_b0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.09.004_b0105","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2217\/nnm-2016-0047","article-title":"Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo","volume":"11","author":"Maisel","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2019.09.004_b0110","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ejpb.2011.06.003","article-title":"Tryptophan-mPEGs: novel excipients that stabilize salmon calcitonin against aggregation by non-covalent PEGylation","volume":"79","author":"Mueller","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.09.004_b0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2014.04.017","article-title":"Assessment of PEG on polymeric particles surface, a key step in drug carrier translation","volume":"185","author":"Rabanel","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.09.004_b0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2012.04.066","article-title":"Emerging trends in the stabilization of amorphous drugs","volume":"453","author":"Laitinen","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.09.004_b0125","unstructured":"ICH Q3C, Committee for Human Medicinal Products ICH guideline Q3C (R7) on impurities: guideline for residual solvents Step 5, Int. Conf. Harmon. 44, 2018."},{"key":"10.1016\/j.ejpb.2019.09.004_b0130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ejps.2010.08.013","article-title":"Preparation and solid state characterisation of chlorothiazide sodium intermolecular self-assembly suprastructure","volume":"41","author":"Paluch","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.09.004_b0135","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejpb.2015.08.002","article-title":"Optimal design for studying mucoadhesive polymers interaction with gastric mucin using a quartz crystal microbalance with dissipation (QCM-D): Comparison of two different mucin origins","volume":"96","author":"Oh","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.09.004_b0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1238\/Physica.Regular.059a00391","article-title":"Viscoelastic acoustic response of layered polymer films at fluid-solid interfaces: continuum mechanics approach","volume":"59","author":"Voinova","year":"1999","journal-title":"Phys. Scr."},{"key":"10.1016\/j.ejpb.2019.09.004_b0145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/17435390902859556","article-title":"Gastrointestinal biodurability of engineered nanoparticles: development of an in vitro assay","volume":"3","author":"Wiecinski","year":"2009","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.ejpb.2019.09.004_b0150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2013.01.019","article-title":"Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size","volume":"453","author":"Sinha","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.09.004_b0155","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejpb.2015.08.005","article-title":"Mesophase and size manipulation of itraconazole liquid crystalline nanoparticles produced via quasi nanoemulsion precipitation","volume":"96","author":"Mugheirbi","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.09.004_b0160","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1039\/c0nr00628a","article-title":"The two-step mechanism of nucleation of crystals in solution","volume":"2","author":"Vekilov","year":"2010","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejpb.2019.09.004_b0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and zeta potential \u2013 what they are and what they are not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.09.004_b0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.addr.2017.11.002","article-title":"The role of mucus as an invisible cloak to transepithelial drug delivery by nanoparticles","volume":"124","author":"Garc\u00eda-D\u00edaz","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.09.004_b0175","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","article-title":"Nanosuspensions in drug delivery","volume":"3","author":"Rabinow","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpb.2019.09.004_b0180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2018.03.054","article-title":"In situ monitoring of nanoparticle formation: antisolvent precipitation of azole anti-fungal drugs","volume":"543","author":"McComiskey","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.09.004_b0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.addr.2016.04.002","article-title":"Crystalline mesophases: structure, mobility, and pharmaceutical properties","volume":"100","author":"Shalaev","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.09.004_b0190","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1021\/acs.cgd.6b00342","article-title":"Crystallization of itraconazole polymorphs from melt","volume":"16","author":"Zhang","year":"2016","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejpb.2019.09.004_b0195","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1021\/acs.molpharmaceut.8b00724","article-title":"Phase diagrams of polymer-dispersed liquid crystal systems of itraconazole\/component immiscibility induced by molecular anisotropy","volume":"15","author":"Kozyra","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2019.09.004_b0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11095-008-9721-1","article-title":"Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters","volume":"26","author":"Marsac","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.09.004_b0205","first-page":"230","article-title":"Characterization of recrystallized itraconazole prepared by cooling and anti-solvent crystallization","volume":"10","author":"Sriamornsak","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.09.004_b0210","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejpb.2018.07.012","article-title":"Comparison of particle size methodology and assessment of nanoparticle tracking analysis (NTA) as a tool for live monitoring of crystallisation pathways","volume":"130","author":"McComiskey","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.09.004_b0215","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1248\/bpb.26.743","article-title":"The correlation between zeta potential and mucoadhesion strength on pig vesical mucosa","volume":"26","author":"Bogataj","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2019.09.004_b0220","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","article-title":"Impact of Surface Polyethylene Glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo","volume":"9","author":"Xu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2019.09.004_b0225","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s11095-010-0073-2","article-title":"Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates","volume":"27","author":"Filipe","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.09.004_b0230","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jconrel.2012.03.013","article-title":"Drug nanocrystals: In vivo performances","volume":"160","author":"Gao","year":"2012","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2019.09.004_b0235","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.09.004_b0240","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.trac.2011.01.005","article-title":"Applications of particle-tracking analysis to the determination of size distributions and concentrations of nanoparticles in environmental, biological and food samples","volume":"30","author":"Gallego-Urrea","year":"2011","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.ejpb.2019.09.004_b0245","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.addr.2017.12.002","article-title":"Technological strategies to estimate and control diffusive passage times through the mucus barrier in mucosal drug delivery","volume":"124","author":"Newby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.09.004_b0250","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejpb.2019.09.004_b0255","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.09.004_b0260","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF01337937","article-title":"Verwendung von Schwingquarzen zur W\u00e4gung d\u00fcnner Schichten und zur Mikrow\u00e4gung","volume":"155","author":"Sauerbrey","year":"1959","journal-title":"Zeitschrift F\u00fcr Phys."},{"key":"10.1016\/j.ejpb.2019.09.004_b0265","doi-asserted-by":"crossref","unstructured":"M. Rodahl, B. Kasemo, On the measurement of thin liquid overlayers with the quartz-crystal microbalance, in: Proc. Int. Solid-State Sensors Actuators Conf. - TRANSDUCERS \u201995, IEEE, 1995, pp. 743\u2013746. https:\/\/doi.org\/10.1109\/SENSOR.1995.721939.","DOI":"10.1109\/SENSOR.1995.721939"},{"key":"10.1016\/j.ejpb.2019.09.004_b0270","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cocis.2005.11.001","article-title":"Mucin structure, aggregation, physiological functions and biomedical applications","volume":"11","author":"Bansil","year":"2006","journal-title":"Curr. Opin. Colloid Interface Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119309440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119309440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:35:01Z","timestamp":1760546101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641119309440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":54,"alternative-id":["S0939641119309440"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.09.004","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of polyethylene glycol polymers on the physicochemical properties and mucoadhesivity of itraconazole nanoparticles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}